Patents by Inventor Michael Wachter

Michael Wachter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060223798
    Abstract: The invention relates to a CB modulator compound of Formula (I) or a pharmaceutically acceptable form thereof and a method for use in treating, ameliorating or preventing a CB receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: March 16, 2006
    Publication date: October 5, 2006
    Inventors: Fina Liotta, Huajun Lu, Mingde Xia, Michael Wachter
  • Publication number: 20060111352
    Abstract: This invention is directed to acetylenic compounds as inhibitors of a nicotinamide adenine dinucleotide oxidase hydride donor useful in treating or ameliorating a reactive oxygen species mediated inflammatory disorder.
    Type: Application
    Filed: January 10, 2006
    Publication date: May 25, 2006
    Inventors: Scott Beers, Elizabeth Malloy, Michael Wachter
  • Publication number: 20060106018
    Abstract: This invention is directed to acetylenic compounds as inhibitors of a nicotinamide adenine dinucleotide oxidase hydride donor useful in treating or ameliorating a reactive oxygen species mediated inflammatory disorder.
    Type: Application
    Filed: January 10, 2006
    Publication date: May 18, 2006
    Inventors: Scott Beers, Elizabeth Malloy, Michael Wachter
  • Publication number: 20060089378
    Abstract: This invention is directed to a tetrahydro-pyridinyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: October 18, 2005
    Publication date: April 27, 2006
    Inventors: Mingde Xia, Meng Pan, Michael Wachter, Fina Liotta
  • Publication number: 20060069123
    Abstract: Substituted dipiperidine compounds of Formula (I) or a salt, isomer, prodrug, metabolite or polymorph thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.
    Type: Application
    Filed: September 12, 2005
    Publication date: March 30, 2006
    Inventors: Mingde Xia, Michael Wachter, Meng Pan, Duane DeMong, Scott Pollack
  • Publication number: 20050228034
    Abstract: This invention is directed to a tetrahydro-indazole cannabinoid modulator compound of formula I: and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: March 23, 2005
    Publication date: October 13, 2005
    Inventors: Bharat Lagu, Fina Liotta, Meng Pan, Michael Wachter, Mingde Xia
  • Publication number: 20050020838
    Abstract: This invention is directed to acetylenic compounds as inhibitors of a nicotinamide adenine dinucleotide oxidase hydride donor useful in treating or ameliorating a reactive oxygen species mediated inflammatory disorder.
    Type: Application
    Filed: July 24, 2003
    Publication date: January 27, 2005
    Inventors: Scott Beers, Elizabeth Malloy, Michael Wachter
  • Publication number: 20040242639
    Abstract: This invention is directed to heterocyclyl-substituted anilino phospholipase C inhibitor compounds useful in treating or ameliorating an inflammatory disorders and/or restenosis of the general formula (I): 1
    Type: Application
    Filed: March 31, 2004
    Publication date: December 2, 2004
    Inventors: Bharat Lagu, Kenneth Rupert, Michael Wachter
  • Publication number: 20040235827
    Abstract: This invention is directed to heterocyclyl-substituted anilino phospholipase C inhibitor compounds useful in treating or ameliorating an inflammatory disorders and/or restenosis of the general formula (I): 1
    Type: Application
    Filed: March 31, 2004
    Publication date: November 25, 2004
    Inventors: Bharat Lagu, Kenneth Rupert, Michael Wachter
  • Publication number: 20040235855
    Abstract: This invention is directed to heterocyclyl-substituted anilino phospholipase C inhibitor compounds useful in treating or ameliorating an inflammatory disorders and/or restenosis of the general formula (I): 1
    Type: Application
    Filed: March 31, 2004
    Publication date: November 25, 2004
    Inventors: Bharat Lagu, Meng Pan, Kenneth Rupert, Michael Wachter
  • Patent number: 6083969
    Abstract: This invention is directed to certain 1,3- and 2,3-diarylpyrazole antiinflammatory compounds of the general formulae: ##STR1## wherein R.sub.1 and R.sub.2 are independently selected from the group consisting of hydrogen, halogen, (C.sub.1 -C.sub.6)alkyl, (C.sub.1 -C.sub.6)alkoxy, nitro, amino, hydroxy, trifluoro, --S(C.sub.1 -C.sub.6)alkyl, --SO(C.sub.1 -C.sub.6)alkyl and --SO.sub.2 (C.sub.1 -C.sub.6)alkyl and the fused moiety Q is a group selected from the group consisting of an optionally substituted cyclohexyl and cycloheptyl group as herein described, pharmaceutical compositions containing the compounds, processes for their production and use as COX-2 inhibitor and antiinflammatory agents.
    Type: Grant
    Filed: October 20, 1999
    Date of Patent: July 4, 2000
    Assignee: Ortho-McNeil Pharaceutical, Inc.
    Inventors: Michael Ferro, Zhihua Sui, Michael Wachter
  • Patent number: 6081044
    Abstract: In a method for tripping a restraint device in a vehicle, coded information signals with status and diagnosis messages are transmitted in both directions between an evaluation device and an ignition device. To avoid the situation where a tripping signal for the restraint device may be delayed in its transmission to the ignition device because the data throughput in the transmission medium is high, the transmission of the information signals is interrupted. Accordingly, the transmission of the information signals in the forward and return directions is controlled by the evaluation device. As a function of a collision signal furnished by a sensor device, the transmission of the information signals is ended by the evaluation device, so that the transmission medium between the evaluation device and the ignition device remains free for a possibly ensuing tripping signal.
    Type: Grant
    Filed: September 8, 1998
    Date of Patent: June 27, 2000
    Assignee: Siemens Aktiengesellschaft
    Inventors: Anton Anthofer, Michael Wachter, Marten Swart
  • Patent number: 6077869
    Abstract: This invention relates to the use of compounds of formula I as selective COX-2 inhibitors and antiinflammatory agents: ##STR1## wherein: X and Y are selected from hydrogen, halogen, alkyl, nitro, amino or other oxygen and sulfur containing functional groups such as hydroxy, methoxy and methylsulfonyl.
    Type: Grant
    Filed: October 20, 1999
    Date of Patent: June 20, 2000
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Zhihua Sui, Michael Wachter
  • Patent number: 6036224
    Abstract: An impact sensor configuration in a motor vehicle includes a sensor device in each vehicle half (relative to the longitudinal axis of the vehicle) for detecting an acceleration. Each sensor device has two acceleration sensors with differently directed sensitivity axes.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: March 14, 2000
    Assignee: Siemens Aktiengesellschaft
    Inventors: Michael Wachter, Marten Swart, Klemens Paul, Anton Anthofer, Gerhard Mader, Richard Vogt
  • Patent number: 6028202
    Abstract: Compounds of Formula I ##STR1## wherein, R.sub.1 through R.sub.7 are described herein. These compounds inhibit the production of arachidonic acid products associated with 5-lipoxygenase and cyclooxygenase and are useful in the treatment of inflammatory disorders.
    Type: Grant
    Filed: December 29, 1998
    Date of Patent: February 22, 2000
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Peter Connolly, Michael Wachter, Robert Chen
  • Patent number: 5925769
    Abstract: Compounds of Formula I ##STR1## wherein, R.sub.1 through R.sub.7 are described herein. These compounds inhibit the production of arachidonic acid products associated with 5-lipoxygenase and cyclooxygenase and are useful in the treatment of inflammatory disorders.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: July 20, 1999
    Assignee: Ortho Pharmaceutical, Corp.
    Inventors: Peter Connolly, Michael Wachter, Robert Chen
  • Patent number: 5880370
    Abstract: In a device for the arrangement of at least one ultrasonic testing head on a tube having a welding seam for the ultrasonic testing of the welding seam of the tube each ultrasonic testing head is built in a support. The support is provided with front and rear support points and led in constant radial distance to the tube on a test trace. The ultrasonic testing head is arranged in the area of the front support points, which are closest to the welding seam to be examined seen in the peripheral direction of the tube. A mechanical scanning device is provided, it is connected to the ultrasonic testing head and is arranged at the support in the area between the front and rear support points. The ultrasonic testing head has a single ultrasonic vibrator.
    Type: Grant
    Filed: August 16, 1995
    Date of Patent: March 9, 1999
    Assignee: Krautkramer GmbH & Co.
    Inventors: Michael Wachter, Kurt Hannoschock, Dieter Grohs, Peter Steinert, Wolfgang Zydek
  • Patent number: 5148414
    Abstract: An electrodynamic ultrasonic transducer, for testing a workpiece, has a pair of spaced permanent magnets, a transducer coil, a concentrator, and a non-ferromagnetic member which partially surrounds the concentrator. In order to concentrate the magnetic lines of flux, the concentrator has a cross-sectional area which is smaller than the cross-sectional area of the adjacent permanent magnets. A transducer coil is acted on by a high frequency transmission pulse, whereby ultrasonics is produced in the workpiece to be tested.
    Type: Grant
    Filed: November 1, 1991
    Date of Patent: September 15, 1992
    Assignee: Mannesmann Aktiengesellschaft
    Inventors: Alfred Graff, Michael Wachter
  • Patent number: 5050703
    Abstract: The invention furnishes an electrodynamic transducer head for a non-destructive testing of workpieces with electrically conductive surfaces by way of ultrasound. A magnet system is employed for generating of a static or a low-frequency magnet field, and at least one transducer coil is disposed at the front face of the magnet system disposed toward the workpiece. The transducer coil is furnished on the side toward the workpiece with a wear-resistant layer, and the transducer coil exhibits between itself and this front face of the magnet system an intermediate part with an insulating layer, which is solidly connected with the front face and with the coil adjoining at the insulating layer.
    Type: Grant
    Filed: October 5, 1989
    Date of Patent: September 24, 1991
    Assignee: Mannesmann Aktiengesellschaft
    Inventors: Alfred Graff, Friedhelm Schlawne, Michael Wachter, Wolfgang Bottger